LNWTC
NVNO

Laird Norton Wetherby Trust Company’s enVVeno Medical NVNO Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-714
Closed -$99.8K – 69
2025
Q2 		$99.8K Hold
714
– – 0.01% 66
2025
Q1 		$65.8K Hold
714
– – 0.01% 66
2024
Q4 		$75.5K Hold
714
– – 0.01% 75
2024
Q3 		$84K Sell
714
-229
-24% -$42.1K 0.01% 77
2024
Q2 		$173K Hold
943
– – 0.02% 59
2024
Q1 		$180K Buy
943
+657
+230% +$118K 0.02% 67
2023
Q4 		$51.4K Buy
+286
New +$45.5K 0.01% 85

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Laird Norton Wetherby Trust Company's NVNO Position: Q3 2025 in Review

Laird Norton Wetherby Trust Company sold out of enVVeno Medical (NVNO) in Q3 2025, closing a stake of 714 shares — an estimated $99.8K sold.

Laird Norton Wetherby Trust Company first reported a position in NVNO in Q4 2023 and held it in 7 quarters. The position peaked at $180K in Q1 2024. 36 funds tracked by Wall St. Rank hold NVNO as of Q3 2025.

  • Laird Norton Wetherby Trust Company reported no remaining enVVeno Medical position as of Q3 2025 after selling out during the quarter.
  • Laird Norton Wetherby Trust Company sold 714 enVVeno Medical shares in Q3 2025, an estimated $99.8K.
  • Laird Norton Wetherby Trust Company first reported a position in enVVeno Medical in Q4 2023 and held it in 7 quarters.
  • Laird Norton Wetherby Trust Company's enVVeno Medical position peaked at $180K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2025.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.